Azais H., Delhem N., Colombeau L., Frochot C., Anne G., Morales O., Mordon S., Collinet P.   WHY SHOULD WE INCREASE RESEARCHES IN PHOTODYNAMIC THERAPY OF PERITONEAL METASTASES OF EPITHELIAL OVARIAN CANCER?.  Int. J. Gynecol. Cancer.  2017 ;27 :1799-1799
Ascierto P., Bastholt L., Mohr P., Hoeller C., Roberts C., Larkins J., Dummer R., Ekbom A., Chiarion-Sileni V., Dutriaux C., Mortier L., Neyns B., Nyakas M., Garbe C., Baurain J. F., Kruse V., Svane I. M., Alfaya L., Ciria C., Blank C.   EURO-VOYAGE: Effectiveness and safety of ipilimumab (IPI) administered during a European Expanded Access Programme (EAP) in patients with advanced melanoma (MEL).  Eur. J. Cancer.  2017 ;72 :S128-S128
Antoine J. M., Azria E., Barranger E., Belaisch-Allart J., Boutet G., Buisson O., Canis M., Chene G., Christin-Maitre S., Collinet P., Deval B., Gallot D., Homasson N., Kayem G., Leblanc E., Madelenat P., Marret H., Mathelin C., Mimoun S., Panel P., Pirot F., Quarello E., Salomon L., Sentilhes L., Sifer C., Simon E., Simon-Bouy B., Yazbeck C.   Roots and wings.  Gynecol. Obstet. Fertil. Senol..  2017 ;45 :1-2
Allayous C., Guillot B., Rat S. D., Mortier L., Dutriaux C., Leccia M. T., Lacour J. P., Dalle S., Saiag P., Beylot-Barry M., Lok C., De Quatrebarbes J., Aubin F., Lesimple T., Dreno B., Porcher R., Ballon A., Oriano B., Lebbe C.   Dabrafenib and Trametinib combination in real life patients including brain metastases: French experience within MelBase.  Ann. Oncol..  2017 ;28
Allayous C., Dalle S., Leccia M. T., Aubin F., Mortier L., Marie Beylot Barry, Saiag P., Dalac-Rat S., Lacour J. P., Maubec E., Descamps V., Guillot B., Lesimple T., De Quatrebarbes J., Arnault J. P., Stoebner P. E., Porcher R., Ballon A., Oriano B., Lebbe C.   Role of time to switch from ipilimumab to anti-PD1 in anti-PD1 efficacy within the French national cohort, MelBase.  J. Clin. Oncol..  2017 ;35 :9551-9551
Aboukaïs R., Vinchon M., Quidet M., Bourgeois P., Leclerc X., Lejeune J. P.   Reappearance of arteriovenous malformations after complete resection of ruptured arteriovenous malformations: true recurrence or false-negative early postoperative imaging result?.  J. Neurosurg..  2017 ;126 :1088-1093

OBJECTIVE Ruptured arteriovenous malformations (AVMs) are often obliterated after emergency microsurgical treatment. However, some studies have reported AVM recurrence after the obliteration of ruptured AVMs. The authors report their experience with AVM recurrence after successful microsurgical treatment of ruptured AVMs. METHODS The authors reviewed the medical data of 139 consecutive patients who underwent microsurgery at the authors' institution for ruptured AVM between 2002 and 2012. Each patient underwent a conventional cerebral angiography examination immediately after the surgery. Subsequent follow-ups were performed with MR angiography after 6 months, and, if there was no indication of AVM recurrence, patients were followed up with conventional cerebral angiography between 1 and 2 years after the treatment; pediatric patients were followed up until age 18 years. Recurrence was defined as new radiological evidence of an AVM at the site of a ruptured AVM or a new hemorrhage in patients with angiographically documented AVM obliteration on postoperative angiograms. RESULTS The mean age of the patients at the time of ruptured AVM diagnosis was 30.8 years (SD +/- 5, range 4-69 years), and 44 of the patients were younger than 18 years (the mean age at diagnosis in this pediatric subgroup was 11.4 years [range 4-17.9 years]). Complete AVM obliteration after the initial microsurgery was observed in 123 patients (89.5%). Reappearance of an AVM was noted in 7 patients between 12 and 42 months after the treatment, and all of these patients were younger than 18 years. The recurrent AVM was located in an eloquent zone in 4 patients, and deep venous drainage was noted in 3 patients. Radiosurgery was performed in 6 of these patients, and 1 patient underwent another microsurgical procedure. The authors noted only one rebleeding due to an AVM recurrence during the latency period after radiosurgery. CONCLUSIONS The recurrence of an AVM is fairly rare and affects mostly pediatric patients. Therefore, especially in children, long-term angiographic follow-up is required to detect AVM recurrence or an AVM remnant. The authors stress the need for discussion involving a multidisciplinary neurosurgical team to decide on treatment in cases of any AVM recurrence or remnant.

Schaefer A., Vermandel M., Baillet C., Dewalle-Vignion A. S., Modzelewski R., Vera P., Massoptier L., Parcq C., Gibon D., Fechter T., Nemer U., Gardin I., Nestle U.   Impact of consensus contours from multiple PET segmentation methods on the accuracy of functional volume delineation.  Eur. J. Nucl. Med. Mol. Imaging.  2016 ;43 :911-924

PURPOSE: The aim of this study was to evaluate the impact of consensus algorithms on segmentation results when applied to clinical PET images. In particular, whether the use of the majority vote or STAPLE algorithm could improve the accuracy and reproducibility of the segmentation provided by the combination of three semiautomatic segmentation algorithms was investigated. METHODS: Three published segmentation methods (contrast-oriented, possibility theory and adaptive thresholding) and two consensus algorithms (majority vote and STAPLE) were implemented in a single software platform (Artiview(R)). Four clinical datasets including different locations (thorax, breast, abdomen) or pathologies (primary NSCLC tumours, metastasis, lymphoma) were used to evaluate accuracy and reproducibility of the consensus approach in comparison with pathology as the ground truth or CT as a ground truth surrogate. RESULTS: Variability in the performance of the individual segmentation algorithms for lesions of different tumour entities reflected the variability in PET images in terms of resolution, contrast and noise. Independent of location and pathology of the lesion, however, the consensus method resulted in improved accuracy in volume segmentation compared with the worst-performing individual method in the majority of cases and was close to the best-performing method in many cases. In addition, the implementation revealed high reproducibility in the segmentation results with small changes in the respective starting conditions. There were no significant differences in the results with the STAPLE algorithm and the majority vote algorithm. CONCLUSION: This study showed that combining different PET segmentation methods by the use of a consensus algorithm offers robustness against the variable performance of individual segmentation methods and this approach would therefore be useful in radiation oncology. It might also be relevant for other scenarios such as the merging of expert recommendations in clinical routine and trials or the multiobserver generation of contours for standardization of automatic contouring.

Azahaf M., Haberley M., Betrouni N., Ernst O., Behal H., Duhamel A., Ouzzane A., Puech P.   Impact of Arterial Input Function Selection on the Accuracy of Dynamic Contrast-Enhanced MRI Quantitative Analysis for the Diagnosis of Clinically Significant Prostate Cancer.  J. Magn. Reson. Imaging.  2016 ;43 :737-749

PURPOSE: Using a limited temporal resolution dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) dataset to assess the impact of the arterial input function (AIF) choice on the transfer constant (K(trans) ) to distinguish prostate carcinoma (PCa) from benign tissue. MATERIALS AND METHODS: Thirty-eight patients with clinically important peripheral PCa (>/=0.5 cc) were retrospectively studied. These patients underwent 1.5T multiparametric prostate MR with PCa and benign regions of interest (ROIs) selected using a visual registration with morphometric reconstruction obtained from radical prostatectomy. Using three pharmacokinetic (PK) analysis software programs, the mean K(trans) of ROIs was computed using three AIFs: an individual AIF (Ind-AIF) and two literature population average AIFs of Weinmann (W-AIF) and of Fritz-Hansen (FH-AIF). A pairwise comparison of the area under the receiver operating characteristic curves (AUROCC) obtained with different AIFs was performed. RESULTS: AUROCCs obtained with W-AIF (ranging from 0.801 to 0.843) were significantly higher than FH-AIF (ranging from 0.698 to 0.780, 0.002

Frimat M., Decambron M., Lebas C., Moktefi A., Lemaitre L., Gnemmi V., Sautenet B., Glowacki F., Subtil D., Jourdain M., Rigouzzo A., Brocheriou I., Halimi J. M., Rondeau E., Noel C., Provôt F., Hertig A.   Renal Cortical Necrosis in Postpartum Hemorrhage: A Case Series.  Am. J. Kidney Dis..  2016 ;68 :50-57

BACKGROUND: Pregnancy-related renal cortical necrosis may lead to end-stage renal disease. Although this obstetric complication had virtually disappeared in high-income countries, we have noted new cases in France over the past few years, all following postpartum hemorrhage. STUDY DESIGN: Case series. SETTING & PARTICIPANTS: We retrospectively identified 18 patients from 5 French nephrology departments who developed renal cortical necrosis following postpartum hemorrhage in 2009 to 2013. OUTCOMES: Obstetric and renal features, therapeutic measures, and kidney disease outcome were studied. RESULTS: All patients had a severe postpartum hemorrhage (mean blood loss, 2.6+/-1.1 [SD] L). Hemodynamic instability and disseminated intravascular coagulation were reported in 5 and 11 patients, respectively. All developed rapid onset of acute kidney injury and required hemodialysis. Diagnosis of renal cortical necrosis was performed 4 to 33 days following delivery. At 6 months postpartum, 8 patients remained dialysis dependent and none recovered normal kidney function. The length of exposure to tranexamic acid treatment was significantly more prolonged in women whose estimated glomerular filtration rate remained <15mL/min/1.73m(2) (7.1+/-4.8 vs 2.9+/-2.4 hours; P=0.03). LIMITATIONS: Retrospective study; small sample size. CONCLUSIONS: In the setting of gravid endothelium, the conjunction of disseminated intravascular coagulation with the life-saving use of procoagulant and antifibrinolytic agents (recently implemented in France in a postpartum hemorrhage treatment algorithm) may give rise to a risk for uncontrolled clotting in the renal cortex and hence irreversible partial or diffuse cortical necrosis.